IBDEI2TI ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44943,1,4,0)
 ;;=4^C84.02
 ;;^UTILITY(U,$J,358.3,44943,2)
 ;;=^5001623
 ;;^UTILITY(U,$J,358.3,44944,0)
 ;;=C84.04^^170^2241^92
 ;;^UTILITY(U,$J,358.3,44944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44944,1,3,0)
 ;;=3^Mycosis Fungoides,Axilla/Upper Limb Lymph Nodes
 ;;^UTILITY(U,$J,358.3,44944,1,4,0)
 ;;=4^C84.04
 ;;^UTILITY(U,$J,358.3,44944,2)
 ;;=^5001625
 ;;^UTILITY(U,$J,358.3,44945,0)
 ;;=C84.01^^170^2241^94
 ;;^UTILITY(U,$J,358.3,44945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44945,1,3,0)
 ;;=3^Mycosis Fungoides,Head/Face/Neck Lymph Nodes
 ;;^UTILITY(U,$J,358.3,44945,1,4,0)
 ;;=4^C84.01
 ;;^UTILITY(U,$J,358.3,44945,2)
 ;;=^5001622
 ;;^UTILITY(U,$J,358.3,44946,0)
 ;;=C84.05^^170^2241^95
 ;;^UTILITY(U,$J,358.3,44946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44946,1,3,0)
 ;;=3^Mycosis Fungoides,Inguinal Region/LE Lymph Nodes
 ;;^UTILITY(U,$J,358.3,44946,1,4,0)
 ;;=4^C84.05
 ;;^UTILITY(U,$J,358.3,44946,2)
 ;;=^5001626
 ;;^UTILITY(U,$J,358.3,44947,0)
 ;;=C84.08^^170^2241^99
 ;;^UTILITY(U,$J,358.3,44947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44947,1,3,0)
 ;;=3^Mycosis Fungoides,Multiple Site Lymph Nodes
 ;;^UTILITY(U,$J,358.3,44947,1,4,0)
 ;;=4^C84.08
 ;;^UTILITY(U,$J,358.3,44947,2)
 ;;=^5001629
 ;;^UTILITY(U,$J,358.3,44948,0)
 ;;=C84.07^^170^2241^100
 ;;^UTILITY(U,$J,358.3,44948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44948,1,3,0)
 ;;=3^Mycosis Fungoides,Spleen
 ;;^UTILITY(U,$J,358.3,44948,1,4,0)
 ;;=4^C84.07
 ;;^UTILITY(U,$J,358.3,44948,2)
 ;;=^5001628
 ;;^UTILITY(U,$J,358.3,44949,0)
 ;;=C84.00^^170^2241^101
 ;;^UTILITY(U,$J,358.3,44949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44949,1,3,0)
 ;;=3^Mycosis Fungoides,Unspec Site
 ;;^UTILITY(U,$J,358.3,44949,1,4,0)
 ;;=4^C84.00
 ;;^UTILITY(U,$J,358.3,44949,2)
 ;;=^5001621
 ;;^UTILITY(U,$J,358.3,44950,0)
 ;;=C43.122^^170^2241^4
 ;;^UTILITY(U,$J,358.3,44950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44950,1,3,0)
 ;;=3^Malig Melanoma of Left Lower Eyelid,Incl Canthus
 ;;^UTILITY(U,$J,358.3,44950,1,4,0)
 ;;=4^C43.122
 ;;^UTILITY(U,$J,358.3,44950,2)
 ;;=^5157252
 ;;^UTILITY(U,$J,358.3,44951,0)
 ;;=C43.121^^170^2241^6
 ;;^UTILITY(U,$J,358.3,44951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44951,1,3,0)
 ;;=3^Malig Melanoma of Left Upper Eyelid,Incl Canthus
 ;;^UTILITY(U,$J,358.3,44951,1,4,0)
 ;;=4^C43.121
 ;;^UTILITY(U,$J,358.3,44951,2)
 ;;=^5157251
 ;;^UTILITY(U,$J,358.3,44952,0)
 ;;=C43.112^^170^2241^12
 ;;^UTILITY(U,$J,358.3,44952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44952,1,3,0)
 ;;=3^Malig Melanoma of Right Lower Eyelid,Incl Canthus
 ;;^UTILITY(U,$J,358.3,44952,1,4,0)
 ;;=4^C43.112
 ;;^UTILITY(U,$J,358.3,44952,2)
 ;;=^5157250
 ;;^UTILITY(U,$J,358.3,44953,0)
 ;;=C43.111^^170^2241^14
 ;;^UTILITY(U,$J,358.3,44953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44953,1,3,0)
 ;;=3^Malig Melanoma of Right Upper Eyelid,Incl Canthus
 ;;^UTILITY(U,$J,358.3,44953,1,4,0)
 ;;=4^C43.111
 ;;^UTILITY(U,$J,358.3,44953,2)
 ;;=^5157249
 ;;^UTILITY(U,$J,358.3,44954,0)
 ;;=C44.1922^^170^2241^30
 ;;^UTILITY(U,$J,358.3,44954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44954,1,3,0)
 ;;=3^Malig Neop Skin of Right Lower Eyelid,Incl Canthus
 ;;^UTILITY(U,$J,358.3,44954,1,4,0)
 ;;=4^C44.1922
 ;;^UTILITY(U,$J,358.3,44954,2)
 ;;=^5157271
 ;;^UTILITY(U,$J,358.3,44955,0)
 ;;=C44.1921^^170^2241^32
 ;;^UTILITY(U,$J,358.3,44955,1,0)
 ;;=^358.31IA^4^2
